Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Wilmington Healthcare

Website
Email
01268 495600

A heritage to envy

Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS and Wellards to create an unrivalled healthcare data, education and information resource with outstanding analytics capabilities. Binley’s is a healthcare data and intelligence provider, which translates the complex NHS environment into useful information that helps organisations to increase sales, save money and improve healthcare. NHiS was founded in 2007 in response to a growing need in the marketplace for quantitative and qualitative data to inform service redesign and pathway efficiencies. Wellards provides the most up-to-date and comprehensive NHS information and training on the market.

What do we do?

Our close connections across the healthcare community, coupled with our high-quality data assets result in effective and actionable insights for our clients. We offer unrivalled expertise in:

  • In depth local UK healthcare knowledge
  • Close relationships with, and proximity to, the NHS
  • The largest collection of data assets in the UK
  • Customised intelligence
  • Service redesign
  • Industry standard-setting unique learning platform

How do we work?

We understand our customers’ requirements, no matter how complex they may be. Our team is skilled at tailoring the right solutions and supporting this journey every step of the way: from supplying data and insight, to engagement opportunities with stakeholders and health sector thought leaders. We will work closely with you to ensure you have the solution that meets your needs.

What results do we get?

Wilmington Healthcare aims to be your data and insight partner. We will provide you with the intelligence you need to transform outcomes for patients and your organisation. Through working with Wilmington Healthcare, our clients develop expertise in their area of focus, helping them to not only gain traction in the market but to achieve market-leading positions and the results to match.

Beechwood House, 2-3 Commercial Way, Christy Close, Southfields, Basildon, SS15 6EF, United Kingdom

- PMLiVE

  • Health data, analytics and insight
  • Education
  • Engagement and collaboration
  • Data, market insight and marketing services
  • NHS service transformation

UNDERSTANDING THE ROLE OF PLACE WITHIN THE NEW NHS: FIVE THINGS INDUSTRY NEEDS TO KNOW

Operating a level below system, “place” is an increasingly important unit of NHS organisation, yet it remains an evolving concept that is not always well-understood among industry practitioners. In this...

MISSION CRITICAL: HOW PHARMA CAN HELP THE NHS IMPROVE CARE FOR OLDER PEOPLE

With around two-thirds of all hospital beds occupied by over-65s, the care of older patients has long been recognised as key to the sustainability of the NHS. So how is...

ALL CHANGE FOR SPECIALISED COMMISSIONING: FOUR THINGS INDUSTRY NEEDS TO KNOW ABOUT THE LATEST REFORMS

With a recent NHSEI policy document confirming that a major shake-up of arrangements for Specialised Commissioning is imminent, Oli Hudson, Content Director at Wilmington Healthcare (wilmingtonhealthcare.com), describes the key changes...

HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW

Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...

ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE

With the Health and Care Act safely passed, Oli Hudson introduces six key stakeholders that will loom large in the new landscape.

Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed

Wilmington Healthcare’s State of the Nation prescribing report shows that spending on sertraline, commonly used to treat depression and anxiety, increased by 305.5% between 2019/20 and 2020/21 while overall spend...

EQUAL FOOTING: HOW PHARMA CAN HELP THE NHS TO ACT ON HEALTH INEQUALITIES

As the NHS puts a renewed focus on reducing health inequalities, Oli Hudson looks at what opportunities this might it bring for Industry and how it can best play its...

UNDERSTANDING THE NEW VALUE PROPOSITION FOR THE NHS

Industry needs a new way of describing its commercial propositions in response to the changing NHS landscape, argues Wilmington Healthcare’s Oli Hudson. This ‘new value proposition’ needs to be reflected...

Wilmington Healthcare appoints new director to lead cloud-based healthcare customer intelligence tool

Paul Rowe to lead intelligence tool that allows Industry to gain the complete picture of their changing NHS customer base and employ precision planning to access target customers and markets.

LOOKING AHEAD: UNDERSTANDING THE NHS CUSTOMER’S PRIORITIES FOR 2022/23

The recently published operational planning guidance describes what the NHS needs to achieve this year. Wilmington Healthcare’s Oli Hudson explores some of its critical themes and what they mean for...

ALL PRESS RELEASES

How does the government plan to reshape the NHS?

Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care

Integrated NHS finances: what do they mean for High Cost Drugs?

Oli Hudson and Steve How, of Wilmington Healthcare, explore NHS England’s new system-level funding and its impact on prescribing for High Cost Drugs

Covid-19: how is it affecting prescribing patterns?

Oli Hudson, Content Director at Wilmington Healthcare, analyses prescribing data in three key disease areas

Harness the power of data to map new patient pathways

Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset

How can pharma align its brand strategy with the NHS Reset?

Oli Hudson, of Wilmington Healthcare, explores how pharma should respond to plans to ‘reboot’ the NHS during the covid recovery era

Covid-19 redefines rules of customer engagement

Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs

Covid-19 drives change in long-term conditions management

Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home

Covid-19: how is it impacting on the NHS Long-term Plan?

Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the plan but put others in jeopardy

Covid-19: what could it mean for the diabetic population?

Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it

Delivering true value: what does it mean for KAM in cancer care?

Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve

ALL WHITE PAPERS

Hear from her: Women's Health Faces Some Difficult Headwinds. Here's How We Can Move Forward

Considering a portfolio review?

Are you considering a portfolio review for your established pharmaceutical brands? Wondering if you should put some activity behind them? At CHASE our experienced team will ensure you maximise your...

Millennial Physicians And Digital Health Services

Can Millennial Physicians and Digital Health Services Fix the Patient-Doctor Relationship?

ALL VIDEOS AND PODCASTS

“High accuracy data, straight-forward customer service and instructions, and a smooth overall experience.”
Christos Begkos, University of Manchester

“Service redesign provided us with development of integrated, person-centred care and greater focus on proactive management of the neurology patients most in need of care.”
CCG Commissioning Lead

“By having jointly agreed guidelines and processes for what are complex – and often confusing – arrangements, it will simplify the system for professionals, as well as patients and carers.”
Marilyn Ekers, Acting Chair of North Yorkshire and York Neurological Alliance

Company Details

Wilmington Healthcare

Email
Website

 Latest Content from  Wilmington Healthcare 

Hear from her: Women's Health Faces Some Difficult Headwinds. Here's How We Can Move Forward

Considering a portfolio review?

Are you considering a portfolio review for your established pharmaceutical brands? Wondering if you should put some activity behind them? At CHASE our experienced team will ensure you maximise your...

UNDERSTANDING THE ROLE OF PLACE WITHIN THE NEW NHS: FIVE THINGS INDUSTRY NEEDS TO KNOW

Operating a level below system, “place” is an increasingly important unit of NHS organisation, yet it remains an evolving concept that is not always well-understood among industry practitioners. In this...

MISSION CRITICAL: HOW PHARMA CAN HELP THE NHS IMPROVE CARE FOR OLDER PEOPLE

With around two-thirds of all hospital beds occupied by over-65s, the care of older patients has long been recognised as key to the sustainability of the NHS. So how is...

ALL CHANGE FOR SPECIALISED COMMISSIONING: FOUR THINGS INDUSTRY NEEDS TO KNOW ABOUT THE LATEST REFORMS

With a recent NHSEI policy document confirming that a major shake-up of arrangements for Specialised Commissioning is imminent, Oli Hudson, Content Director at Wilmington Healthcare (wilmingtonhealthcare.com), describes the key changes...

HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW

Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...

ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE

With the Health and Care Act safely passed, Oli Hudson introduces six key stakeholders that will loom large in the new landscape.

Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed

Wilmington Healthcare’s State of the Nation prescribing report shows that spending on sertraline, commonly used to treat depression and anxiety, increased by 305.5% between 2019/20 and 2020/21 while overall spend...

EQUAL FOOTING: HOW PHARMA CAN HELP THE NHS TO ACT ON HEALTH INEQUALITIES

As the NHS puts a renewed focus on reducing health inequalities, Oli Hudson looks at what opportunities this might it bring for Industry and how it can best play its...

UNDERSTANDING THE NEW VALUE PROPOSITION FOR THE NHS

Industry needs a new way of describing its commercial propositions in response to the changing NHS landscape, argues Wilmington Healthcare’s Oli Hudson. This ‘new value proposition’ needs to be reflected...